D

Daniel Edmonston

Duke University

ORCID: 0000-0003-2589-6993

Publishes on Diabetes Treatment and Management, COVID-19 Clinical Research Studies, Dialysis and Renal Disease Management. 61 papers and 3.7k citations.

PubIndex Score95Top 5% · mid-careerHow it's scored

61Publications

3.7kTotal Citations

First publication: 2010First senior author: 2024

Diabetes Treatment and Management COVID-19 Clinical Research Studies Dialysis and Renal Disease Management Heart Failure Treatment and Management Chronic Kidney Disease and Diabetes

Top publicationsby citations

Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic

Andrew M. South, Matthew A. Sparks, Laurie A. Tomlinson et al.|Nature Reviews Nephrology|2020

Cited by 292

FGF23 at the crossroads of phosphate, iron economy and erythropoiesis

Daniel Edmonston, Myles Wolf|Nature Reviews Nephrology|2019

Cited by 239

Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States

Jennifer E. Flythe, Samantha K. Brenner, Alexandre M. Shehata et al.|American Journal of Kidney Diseases|2020

Cited by 234

Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial

Jordana B. Cohen, Julio A. Chirinos, Thomas C. Hanff et al.|The Lancet Respiratory Medicine|2021

Cited by 224

FGF23 and klotho at the intersection of kidney and cardiovascular disease

Daniel Edmonston, Myles Wolf, Alexander Grabner|Nature Reviews Cardiology|2023

Cited by 116